Product NDC: | 0409-2122 |
Proprietary Name: | Enalaprilat |
Non Proprietary Name: | ENALAPRILAT |
Active Ingredient(s): | 1.25 mg/mL & nbsp; ENALAPRILAT |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-2122 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075458 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090915 |
Package NDC: | 0409-2122-02 |
Package Description: | 1 VIAL in 1 CARTON (0409-2122-02) > 2 mL in 1 VIAL |
NDC Code | 0409-2122-02 |
Proprietary Name | Enalaprilat |
Package Description | 1 VIAL in 1 CARTON (0409-2122-02) > 2 mL in 1 VIAL |
Product NDC | 0409-2122 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ENALAPRILAT |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20090915 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | ENALAPRILAT |
Strength Number | 1.25 |
Strength Unit | mg/mL |
Pharmaceutical Classes |